United States District Court for the District of Columbia
May 21, 2004.
IN RE LORAZEPAM & CLORAZEPATE ANTITRUST LITIGATION; This Order applies to: HEALTH CARE SERVICE CORPORATION, et al, Plaintiffs
MYLAN LABORATORIES, INC., et al, Defendants; BLUE CROSS BLUE SHIELD OF MINNESOTA, BLUE CROSS BLUE SHIELD OF MASSACHUSETTS, and FEDERATED MUTUAL INSURANCE COMPANY, Plaintiffs v. MYLAN LABORATORIES, INC. et al., Defendants
The opinion of the court was delivered by: THOMAS HOGAN, Chief Judge, District
Upon consideration of Mylan's Motion to Modify the Protective Order,
the Opposition of Third-Party AdvancePCS Health, L.P., and Mylan's
Response thereto, it is hereby ORDERED that the Motion [# 572] is GRANTED IN PART and DENIED IN PART.
Specifically, the Motion is denied as to AdvancePCS, and granted as to all
of the other approximately 109 parties and third-parties served with
notice of the motion. In this light, it is further
ORDERED that each Party may execute and serve no more than two
affidavits from in-house attorneys and one affidavit of an in-house
business person in the form attached to the Motion as Exhibits A and B
[as appropriate]. The Parties must serve a copy of each affidavit on all
third parties that have produced documents pursuant to the Protective
Order in this case. If there is no objection by the third parties within
eleven days of service, the affiants will have access to material
produced in this litigation that has been designated CONFIDENTIAL and
HIGHLY CONFIDENTIAL, and it is further
ORDERED that all affiants covered by this Order shall at all times
comply with the terms of the March 16, 1999 Protective Order, including,
without limitation, the requirement that individuals receiving
CONFIDENTIAL or HIGHLY CONFIDENTIAL material agree to maintain all such
confidential information in a manner distinct from the ordinary
operations of his or her employer, so as to eliminate access to this
material by others within (or outside) the company.
© 1992-2004 VersusLaw Inc.